Company Overview
Snapshot
Founded in May 2017 by Omri Nechmadi Naveh, Ronny Barak, and Elad Einav, EndoGI Medical operates with 1–10 employees. The company has raised $54.68K across three funding rounds from two investors. In July 2020, EndoGI Medical received FDA approval for its technology, enabling the simultaneous insertion of two stents into bile ducts.
Business overview
EndoGI Medical is a medical device company focused on developing advanced solutions for gastrointestinal conditions. The company's core technology is a multiple stent placement delivery system designed to treat biliary and pancreatic duct stenosis and strictures caused by various medical issues. This system facilitates the insertion and placement of two or more plastic stents in the common bile or hepatic ducts with a single passage, maintaining guidewire access. EndoGI Medical serves the healthcare industry, specifically targeting hospitals, doctors, and clinics within the gastroenterology and medical devices sectors.
Strategic signal
In July 2020, EndoGI Medical secured FDA approval for its innovative technology, which allows for the simultaneous insertion of two stents into bile ducts. This approval is a significant validation of the company's technology, indicating its potential to reduce patient exposure to infections and other life-threatening complications associated with traditional single-stent insertion methods. This milestone signals strong regulatory acceptance and opens pathways for market entry and clinical use in the United States and Israel, positioning the company for commercial growth.
Log in to access full profile ›Company Intelligence Q&A
- What is EndoGI Medical's primary focus?
- EndoGI Medical is a medical device company specializing in advanced gastrointestinal solutions, particularly developing a multiple stent placement delivery system for biliary and pancreatic duct stenosis and strictures.
- When was EndoGI Medical founded and by whom?
- EndoGI Medical was founded in May 2017 by Omri Nechmadi Naveh, Ronny Barak, and Elad Einav.
- What significant regulatory approval did EndoGI Medical receive?
- In July 2020, EndoGI Medical received FDA approval for its technology, which enables the simultaneous insertion of two stents into bile ducts.
- What is the primary benefit of EndoGI Medical's stent placement technology?
- EndoGI Medical's system allows for the insertion and placement of two or more plastic stents in the common bile or hepatic ducts with one passage, significantly reducing the risk of infections and complications for patients compared to repetitive single-stent insertions.